Famotidine rarely causes drowsiness. In clinical trials, drowsiness (listed as “somnolence” on the label) was reported so infrequently that it didn’t even reach the 1% threshold needed to rank among the drug’s common side effects. The most frequently reported side effects were headache (4.7%), diarrhea (1.7%), dizziness (1.3%), and constipation (1.2%). Drowsiness is possible but unlikely for most people taking standard doses.
Why Famotidine Is Less Sedating Than Other Antihistamines
Famotidine is an H2 antihistamine, meaning it blocks histamine receptors in the stomach to reduce acid production. The antihistamines most people associate with drowsiness, like diphenhydramine (Benadryl), are H1 antihistamines. These are a completely different class of drug that targets histamine receptors in the brain and throughout the body.
First-generation H1 antihistamines are highly fat-soluble and easily cross into the brain, where they block histamine signals involved in wakefulness. That’s why diphenhydramine, doxylamine, and hydroxyzine cause noticeable sedation. Famotidine does cross the blood-brain barrier, but it’s selective for H2 receptors, which play a much smaller role in alertness. The practical result is that most people feel no change in energy or mental sharpness when taking it.
Who Is More Likely to Feel Drowsy
Two groups face a higher risk of central nervous system effects from famotidine: older adults and people with moderate to severe kidney problems. The FDA label specifically warns about CNS reactions in these populations, including confusion, disorientation, agitation, lethargy, and, in rare cases, hallucinations or seizures. Lethargy, which can feel like drowsiness or excessive tiredness, is the most relevant concern here.
The reason comes down to how the body clears the drug. Famotidine is primarily eliminated through the kidneys. Research measuring blood levels in healthy young adults, healthy older adults, and patients with kidney dysfunction found that both aging and reduced kidney function slowed the drug’s elimination. When famotidine lingers longer in the bloodstream, it can accumulate and increase the chance of side effects, including those affecting the brain. For people with severe kidney impairment, doctors typically adjust the dose or extend the time between doses to prevent buildup.
In infants treated for reflux, a small clinical study of 35 patients found agitation rather than drowsiness as the notable behavioral side effect, occurring in 5 of those children.
Famotidine, Alcohol, and Other Sedating Substances
One common concern is whether famotidine makes alcohol hit harder. A study looking at 28 days of famotidine therapy found that the drug did not significantly change peak blood alcohol levels or the overall alcohol response after drinking beer. So famotidine doesn’t appear to amplify alcohol’s sedative effects the way some medications do.
That said, the UK patient information leaflet for famotidine advises against driving or operating machinery if you experience dizziness or headache while taking it. Since dizziness affects roughly 1 in 80 users, it’s worth paying attention to how you feel during the first few days, especially if you’re combining famotidine with anything else that causes drowsiness.
What to Watch For
If you’ve just started famotidine and feel unusually sleepy, it’s worth noting but not alarming on its own. Mild drowsiness is a recognized but uncommon reaction. The more concerning signs to be aware of are confusion, disorientation, or hallucinations, which warrant immediate medical attention and are almost exclusively reported in elderly patients or those with significant kidney disease.
For the average person taking over-the-counter famotidine (Pepcid) for heartburn or acid reflux, drowsiness is one of the least likely side effects you’ll experience. Most people take it without noticing any change in alertness at all.